N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸

N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸

中文名称N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸
中文同义词N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸;芴甲氧羰基-苏氨酸(半乳糖胺(AC)3-Α-D)基;FMOC-THR[GALNAC(AC)3-伪-D]-OH;N-芴甲氧羰基-O-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-Α-D-吡喃半乳糖基)-L-苏氨酸;N-芴甲氧羰基-O-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸;N-芴甲氧羰基-O-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-Α-D-吡喃半乳糖基)-L-苏氨酸,GALNAC L-THREONINE;半乳糖胺L-苏氨酸;N-芴甲氧羰基-O-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-Α-D-吡喃半乳糖基)-L-苏氨酸
英文名称FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH
英文同义词N-FMOC-O-(3,4,6,-TRI-O-ACETYL-2-ACETAMIDO-2-DEOXY-Α-D-GALACTOPYRANOSYL)-L-THREONINE;Fmoc-L-Ser(α-D-GalNAc(Ac)3)-OH;Fmoc-L-Thr(GalNAc(Ac)3-α-D)-OH;Fmoc-O-β-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-galactopyranosyl)-L-threonine≥ 97% (HPLC);Fmoc-Thr(AcAcNH-α-Gal)-OH Novabiochem;N-FMOC-O-(2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE;Fmoc-O-β-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-galactopyranosyl)-L-threonine;Fmoc-L-Thr(α-D-GalNAc(Ac)3)-OH
CAS号116783-35-8
分子式C33H38N2O13
分子量670.66
EINECS号
相关类别糖基氨基酸;糖基化氨基酸;生化试剂;糖氨基酸和糖肽;基准试剂;Glycoamino Acid;Amino Acid;Carbohydrates & Derivatives;Fluorescent Labels & Indicators;Inhibitors;Protein Kinase Inhibitors and Activators
Mol文件116783-35-8.mol
结构式N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸 结构式

N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸 性质

熔点178-183°C
沸点857.1±65.0 °C(Predicted)
密度1.38±0.1 g/cm3(Predicted)
储存条件-20°C
酸度系数(pKa)3.32±0.10(Predicted)
旋光性 (optical activity)[α]22/D +55.0°, c = 1% in chloroform
InChIKeyOXLCJWGAUPPZQJ-ZNHCDWFHSA-N

N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸 用途与合成方法

Fmoc-Thr[GalNAc(Ac)3-α-D]-OH 是用于研究制备癌症疫苗的结构单元。

The O-glycosidic linkage and the O-acetyl protection in this building block is stable to both piperidine and TFA, making it completely compatible with standard protocols in Fmoc solid phase peptide synthesis. The Tn antigen is a tumor-associated carbohydrate antigen that is not normally expressed in peripheral tissues or blood cells. Expression of this antigen, which is found in a majority of human carcinomas of all types, arises from a blockage in the normal O-glycosylation pathway in which glycans are extended from the common precursor GalNAcα1-O-Ser/Thr (Tn +antigen). This precursor is generated in the Golgi apparatus on newly synthesized glycoproteins by a family of polypeptide α- N-acetylgalactosaminyltransferases (ppGalNAcTs) and then extended to the common core 1 O-glycan Galβ1-3GalNAcα1-OSer/Thr (T antigen) by a single enzyme termed the T-synthase (core 1 β3-galactosyltransferase or C1GalT). Formation of the active form of the T-synthase requires a unique molecular chaperone termed Cosmc, encoded by Cosmc on the X-chromosome.

安全信息

WGK Germany3
海关编码2932 99 00

MSDS信息

更新日期产品编号产品名称CAS号包装价格
2024/01/25HY-P0232N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸
Fmoc-Thr[GalNAc(Ac)3-α-D]-OH
116783-35-825mg1900元
2024/01/25HY-P0232N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸
Fmoc-Thr[GalNAc(Ac)3-α-D]-OH
116783-35-850mg3040元

N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸 上下游产品信息

"N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸"相关产品信息
半乳糖苏氨酸 N-FMOC-O-(3,4,6-TRI-O-ACETYL-2-ACETAMIDO-2-DEOXY-Β-D-GLUCOPYRANOSYL)-L-SERINE 半乳糖丝氨酸 葡萄糖苏氨酸 甘露糖苏氨酸 N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-丝氨酸 N-芴甲氧羰基-O-BETA-(2-乙酰氨基-2-脱氧-3,4,6-三-O-乙酰基-ALPHA-D-吡喃半乳糖基)-L-苏氨酸 [2-(2-叠氮基乙氧基)乙氧基]乙基2,3,4,6-四-O-乙酰基-D-吡喃半乳糖苷 2-乙酰胺基-2-脱氧-D-半乳糖 Fmoc-L-苏氨酸 Fmoc-L-丝氨酸
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 | 评选活动 | HS海关编码 | MSDS查询 | 化工站点

Copyright © 2016-2023 ChemicalBook 版权所有  京ICP备07040585号  京公海网安备11010802032676号  

互联网增值电信业务经营许可证:京ICP证150597号  互联网药品信息服务资格证编号(京)-非经营性-2015-0073  信息系统安全等级保护备案证明(三级)  营业执照公示

根据相关法律法规和本站规定,单位或个人购买相关危险物品应取得有效的资质、资格条件。
参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》《互联网危险物品信息发布管理规定》